SCHEMBL4889486

SCHEMBL4889486

O=C(O)c1[nH]c2ccc(NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)cc2c1-c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.59
MAPT P10636 2/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
GFER P55789 3/20 0.48
GAA P10253 2/20 0.48
GSK3A P49840 1/20 0.48
GSK3B P49841 1/20 0.48
CDK5 Q00535 1/20 0.48
CDK5R1 Q15078 1/20 0.48
FFAR4 Q5NUL3 1/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MAP2 P11137 1/20 0.47
BRD4 O60885 2/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.46
CA1 P00915 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3943386 0.91 SERPINE1 (0.56) SERPINE1MAPTFFAR4BRD4PTGDR2
SCHEMBL3946729 0.87 SERPINE1 (0.53) SERPINE1MAPTMEN1KMT2AFFAR4
SCHEMBL4069649 0.87 SERPINE1 (0.56) SERPINE1MAPTMEN1KMT2AGAA
SCHEMBL4894868 0.87 MEN1 (0.55) SERPINE1MAPTMEN1KMT2AGFER
SCHEMBL3948032 0.84 SERPINE1 (0.55) SERPINE1MAPTFFAR4BRD4PTGDR2
SCHEMBL3945167 0.83 BRD4 (0.61) SERPINE1MAPTMEN1KMT2AGFER
Dimethylamine SCHEMBL4931369 0.82 BRD4 (0.59) SERPINE1MAPTMEN1KMT2AGFER
SCHEMBL3952131 0.80 SERPINE1 (0.51) SERPINE1MAPTFFAR4BRD4PTGDR2
SCHEMBL3950737 0.79 MEN1 (0.58) SERPINE1MAPTMEN1KMT2AGFER
SCHEMBL4933597 0.79 GPR35 (0.53) SERPINE1MAPTMEN1KMT2AGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES WYETH (US) 2008-12-25 US claimed
US-7442805-B2 Substituted sulfonamide-indoles WYETH (US) 2008-10-28 US claimed
US-20050096377-A1 Substituted sulfonamide-indoles WYETH (US) 2005-05-05 US claimed
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES WYETH (US) 2008-12-25 US disclosed
US-7442805-B2 Substituted sulfonamide-indoles WYETH (US) 2008-10-28 US disclosed
US-20050096377-A1 Substituted sulfonamide-indoles WYETH (US) 2005-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES STS, TPST2, IDO2 SERPINE1 4706/4885MAPT 2124/4885MEN1 3530/4885
US-20050096377-A1 Substituted sulfonamide-indoles STS, TPST2, IDO2 SERPINE1 4706/4885MAPT 2124/4885MEN1 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.